Volume 7, Issue 2 (Fall & Winter 2024)                   J Res Urol 2024, 7(2): 64-68 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amjadi M, Hemmati Ghavshough M, Farhangi Jahangir F, Sepehran E, Bandehagh H, MohammadRahimi M. Evaluation of the Effectiveness of Shock Wave Therapy in the Treatment of Peyronie's Disease among Patients Visiting Imam Rezai Hospital in Tabriz between 2021-2023. J Res Urol 2024; 7 (2) :64-68
URL: http://urology.umsha.ac.ir/article-1-147-en.html
1- Urology Department, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
2- Medical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
3- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
4- Urology Department, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran , mm.rahimi1357@gmail.com
Abstract:   (1125 Views)
Background and Objective: Peyronie's disease is a relatively rare urological disorder that can cause pain during erection, penile angle deviation, and sexual dysfunction due to the formation of plaque in the tunica albuginea part of the male penis. Extracorporeal shock wave therapy (ESWT) for the management of Peyronie's disease is one of the emerging interventions. In this study, we aim to explore the effects of ESWT on Peyronie's disease.
Materials and Methods: We studied patients with the acute phase of Peyronie's who were treated with ESWT during the past two years, from 2021 to 2023. All patients were referred to the urology clinic of Imam Reza Hospital. Information including age, characteristics of fibrotic plaques, concurrent treatments other than ESWT, International Erectile Dysfunction Index (IIEF-5), and the severity of pain was extracted and documented from the patients' records by the urologist before and after the treatment.
Results: The average age of the studied patients was 54.1 years. Eight percent of patients had a history of trauma to the penis, 30% suffered from diabetes, and 36% had high blood pressure. According to the statistical analysis, ESWT reduced pain and elevated the IIEF-5 score. However, this treatment had no impact on the length of the plaque.
Conclusion: ESWT, as a non-invasive intervention, can lessen pain sooner than the normal progression of the disease and improve the sexual performance of the individual. However, this approach had no significant effect on the length of Peyronie's plaque.
 
Full-Text [PDF 669 kb]   (318 Downloads)    
Type of Study: Research | Subject: Endourology
Received: 2024/03/24 | Accepted: 2024/08/8 | Published: 2024/12/16

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Research in Urology

Designed & Developed by : Yektaweb